• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home ENT

Possible risk factors for sphenoid sinus tumor recurrence identified

byChaz Carrier
November 29, 2014
in ENT, Oncology
Reading Time: 2 mins read
Possible risk factors for sphenoid sinus tumor recurrence identified
Share on FacebookShare on Twitter

1. Tumor recurrence with inverted papilloma is more likely if the initial tumor involves the carotid artery or optic nerve or is identified as carcinoma in situ.

2. Sphenoid sinus inverted papilloma is associated with a 14.6% rate of recurrence after surgery and age is associated with a decrease in the rate of recurrence.

Evidence Rating Level: 3 (Average)

Study Rundown: Inverted papilloma (IP) is one of the most common benign tumors of the nasal cavity and paranasal sinuses. Surgery is the first-line treatment for IP due to an increased risk of malignancy if left untreated. IP originating from the sphenoid sinus is often challenging to completely remove due its proximity to vital structures, which potentially increases the risk of tumor recurrence and malignant transformation. In this study, the authors evaluated clinical risk factors for sphenoid sinus IP recurrence that could be used to improve the current management paradigm. They found that sphenoid sinus IP was associated with a 14.6% rate of recurrence after surgery. Importantly, they demonstrated that IP involving the carotid artery or optic nerve, or with dysplasia or carcinoma in situ (CIS) were associated with a higher risk of recurrence. Though this study’s sample size is the largest to date, it still remains small enough to limit generalizability. Although the rate of recurrence for sphenoid sinus IP has been reported previously, this is the first study to evaluate clinical risk factors for tumor recurrence.

Click to read the study in Laryngoscope

Relevant Reading: Inverted papilloma of the sphenoid sinus: clinical presentation, management, and systematic review of the literature

RELATED REPORTS

No Content Available

In-Depth [case-control study]: This retrospective study involving 48 patients from 7 academic institutions across North America, included patients who underwent endoscopic resection of sphenoid sinus IP during 1996 to 2014. Median follow-up period was 14 months and none of the patients developed a malignancy during this study period. Potential risk factors for tumor recurrence were assessed using the bivariate analyses of the Anderson and Gill Cox model. In this study, the authors found that IP associated with the carotid artery or optic nerve had a 4.76 times greater likelihood of recurrence compared to other tumor sites (RR=4.76; p=0.073). In addition, they found that IP associated with dysplasia or CIS had a 3.6 times greater rate of recurrence (RR=3.6; p=0.08) while older age was associated with lower rate of recurrence (RR=0.95; p=0.063).

More from this author: Double-opposing Z-plasty may improve cleft palate outcomes, Animal regenerative matrix appears safe in breast reconstruction, Elective neck dissection may be unnecessary for adenoid cystic carcinoma

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: inverted papillomasphenoid sinus
Previous Post

Dual-energy CT may improve detection of acute small bowel ischemia

Next Post

Non-surgical outpatient treatment for CIN shows promise

RelatedReports

No Content Available
Next Post
Non-surgical outpatient treatment for CIN shows promise

Non-surgical outpatient treatment for CIN shows promise

Patient Basics: Endocarditis

RAS mutation linked with survival in metastatic colorectal cancer

CT colonography may help distinguish chronic diverticular disease from cancer

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
  • Real-time AI guidance enters live brain tumor surgery
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.